Chengda Pharmaceuticals Hits Day High with 12.86% Surge in Stock Price

Chengda Pharmaceuticals Co., Ltd. has experienced significant activity today, with the stock surging by 12.86% on March 27, 2026. The stock reached an intraday high of CNY 46.68, reflecting a strong performance compared to the broader market, as the China Shanghai Composite index only gained 0.63% on the same day. Over the past week, Chengda Pharmaceuticals has shown a notable increase of 13.77%, while the one-month performance stands at 4.96%. Impressively, the stock has delivered a remarkable 131.01% return over the past year, significantly outperforming the China Shanghai Composite's 16.01% gain. Despite these positive short-term trends, the company faces challenges in management efficiency, with a low Return on Capital Employed (ROCE) of 7.29%. Additionally, the company has reported negative results for the last four consecutive quarters, raising concerns about its long-term growth potential. With a market capitalization of CNY 3,475 million, Chengda Pharmaceuticals remains a mid-cap player in the Pharmaceuticals & Biotechnology industry, navigating a complex financial landscape.